DANIEL R CANCHOLA
Allopathic & Osteopathic Physicians|Family Medicine IRVING, TX NPI 1184771347
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine TX Abbott Laboratories All categories
General Payments — all program years on this page
$87.08
- Category: General Payments
- Program years: PY2018
- Record count: 6
- As of (CMS publication): 2026-01-23
Latest program year (PY2018): $87.08 across 6 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2018) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $87.08 | 6 |
By paying entity
Latest program year (PY2018) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $23.88 | 1 |
| GlaxoSmithKline, LLC. | $14.95 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.96 | 1 |
| Acerta Pharma LLC | $12.40 | 1 |
| Horizon Pharma plc | $11.02 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $10.87 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2018 | $87.08 | 6 |
Records — PY2018 (6)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 561682111 | AstraZeneca Pharmaceuticals LP | $12.40 | 04/20/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 583003713 | Horizon Pharma plc | $11.02 | 02/01/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 589241187 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $10.87 | 01/05/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 589841081 | Takeda Pharmaceuticals U.S.A., Inc. | $13.96 | 10/04/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 596572497 | GlaxoSmithKline, LLC. | $14.95 | 11/20/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 613118607 | Abbott Laboratories | $23.88 | 04/10/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.